Steve Kanner, PhD, the chief scientific officer of Caribou Biosciences, discussed results from preclinical research evaluating the gene editing approach.
Steve Kanner, PhD
Advertisement
Articles by Steve Kanner, PhD
The chief scientific officer of Caribou Biosciences discussed results from preclinical research evaluating the gene editing approach.
The chief scientific officer of Caribou Biosciences discussed the company’s platform for genome editing.
Advertisement
Latest Updated Articles
Steve Kanner, PhD, on Caribou’s chRDNA TechnologyPublished: July 14th 2024 | Updated:
Advertisement
Advertisement
